Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Warm Autoimmune Hemolytic Anemia”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Not applicableTemporarily Not AvailableNCT05221619
What this trial is testing

Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02612558
What this trial is testing

A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Testing effectiveness (Phase 2)Ended earlyNCT02389231
What this trial is testing

Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment

Who this might be right for
Autoimmune Hemolytic Anemia
University Hospital, Bordeaux 2
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)WithdrawnNCT04956276
What this trial is testing

Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT03075878
What this trial is testing

A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01345708
What this trial is testing

A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 23
Large-scale testing (Phase 3)Looking for participantsNCT07086976
What this trial is testing

Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Haemolytic Anaemia
Sanofi 90
Testing effectiveness (Phase 2)Study completedNCT04691570
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Annexon, Inc. 7
Not applicableLooking for participantsNCT05925023
What this trial is testing

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Large-scale testing (Phase 3)Active Not RecruitingNCT04119050
What this trial is testing

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC 118
Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Not applicableNot Yet RecruitingNCT06847607
What this trial is testing

Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic Anemia
Bing Han 20
Large-scale testing (Phase 3)Enrolling By InvitationNCT04138927
What this trial is testing

Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05648968
What this trial is testing

Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Novartis Pharmaceuticals 90
Testing effectiveness (Phase 2)Ended earlyNCT04253236
What this trial is testing

To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Immunovant Sciences GmbH 5
Early research (Phase 1)Study completedNCT02502903
What this trial is testing

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Who this might be right for
Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)+1 more
Bioverativ, a Sanofi company 122
Large-scale testing (Phase 3)Ended earlyNCT05073458
What this trial is testing

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Incyte Corporation 13
Next Page